ACF Bioservices is an analytical CRO dedicated to supporting gene and cell therapies. Our gene and cell therapy analytical services include but are not limited to de novo assay development through qualification, validation and GMP-compliant release testing. We have experience with gene, cell and immunotherapies.
Below is a partial list of our capabilities and qualifications and appended is a brief overview of our services:
• Potency Release Assays
• Stability Assays
• Neutralizing Antibody Assays
• Cytokine Release Assays
• Vector Infectivity
• In vivo Biodistribution, Efficacy, Toxicology (ddPCR, qPCR, RT-PCR)
• ELISA development through validation
• Westerns, Luminescence, Electrophoresis, Chromatography
• Flow Cytometry
• FDA inspected and approved for commercial release testing
• MHRA certified facility for commercial release testing
ACF also provides non-GLP and GLP in vivo services at our San Diego vivarium.
About ACF/Absorption Systems:
Absorption Systems is a full service nonclinical contract research organization (CRO) developing innovative services and solutions for the pharmaceutical, biotech, medical device and regenerative medicine industry. Our services include research and testing for small molecules, large molecules, biologics, medical device and cell and gene therapy products. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated outcomes when they occur. The company's facilities are located in Philadelphia, San Diego, and Boston, servicing hundreds of customers throughout the world. Our facilities are USDA registered, NIH assured, AAALAC accredited, GLP & cGMP compliant, ISO certified, DEA licensed, OLAW assured and FDA inspected. Our focus is to maintain accuracy, timelines, and reliability at every stage of development.